NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Colorectal Cancer

Interventions: Bevacizumab

This observational multicenter study will evaluate the differences in progression-free survival defined in specific subgroups of participants with metastatic colorectal cancer receiving bevacizumab (Avastin). Further, safety and efficacy in daily routine will be assessed.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Participants with metastatic colorectal cancer where physician has decided to give a first-line, fluoro-pyrimidine-based combination therapy with bevacizumab according to Summary of Product Characteristics (SmPC)

Exclusion Criteria:

* Contraindications for bevacizumab according to SmPC